Want to see SE:BOUL full AI Analyst Report?
Boule Diagnostics AB (BOUL) Income Statement
Boule Diagnostics AB Income Statement
Last quarter (Q3 2026), Boule Diagnostics AB's total revenue was $96.20M, a decrease of 24.37% from the same quarter last year. In Q3, Boule Diagnostics AB's net income was $-2.50M. See Boule Diagnostics AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 489.70M | $ 558.60M | $ 571.33M | $ 548.09M | $ 463.34M | |
| $ 213.80M | $ 252.40M | $ 249.71M | $ 227.91M | $ 198.63M | |
| $ 209.29M | $ 509.80M | $ 210.40M | $ 194.43M | $ 162.78M | |
| Depreciation and Amortization | $ 18.60M | $ 22.94M | $ 24.61M | $ 27.18M | $ 21.48M |
| $ 23.12M | $ -255.90M | $ 65.98M | $ 57.84M | $ 55.69M | |
| $ 4.52M | $ -257.40M | $ 39.30M | $ 28.97M | $ 36.02M | |
| $ -42.61M | $ -11.10M | $ -9.20M | $ -8.12M | $ -7.25M | |
| $ 5.90M | $ -268.50M | $ 30.10M | $ 20.85M | $ 28.77M | |
| $ -3.80M | $ -223.30M | $ 24.98M | $ 12.73M | $ 23.27M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.10 | $ -5.75 | $ 0.64 | $ 0.46 | $ 0.85 |
| Diluted EPS | $ -0.10 | $ -5.75 | $ 0.64 | $ 0.45 | $ 0.83 |
| Weighted Average Shares Outstanding | 38.00M | 38.83M | 39.03M | 27.94M | 27.42M |
| Weighted Average Shares Outstanding (Diluted) | 38.00M | 38.83M | 39.06M | 28.48M | 28.17M |
Currency in SEK
